Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease ; volume:13 ; number:1 ; day:26 ; month:9 ; year:2018 ; pages:1-21 ; date:12.2018
Molecular neurodegeneration ; 13, Heft 1 (26.9.2018), 1-21, 12.2018
- Urheber
-
Dumbacher, Michael
- Beteiligte Personen und Organisationen
-
Van Dooren, Tom
Princen, Katrien
De Witte, Koen
Farinelli, Mélissa
Lievens, Sam
Tavernier, Jan
Dehaen, Wim
Wera, Stefaan
Winderickx, Joris
Allasia, Sara
Kilonda, Amuri
Spieser, Stéphane
Marchand, Arnaud
Chaltin, Patrick
Hoogenraad, Casper C.
Griffioen, Gerard
SpringerLink (Online service)
- DOI
-
10.1186/s13024-018-0283-3
- URN
-
urn:nbn:de:101:1-2018111016092342048816
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dumbacher, Michael
- Van Dooren, Tom
- Princen, Katrien
- De Witte, Koen
- Farinelli, Mélissa
- Lievens, Sam
- Tavernier, Jan
- Dehaen, Wim
- Wera, Stefaan
- Winderickx, Joris
- Allasia, Sara
- Kilonda, Amuri
- Spieser, Stéphane
- Marchand, Arnaud
- Chaltin, Patrick
- Hoogenraad, Casper C.
- Griffioen, Gerard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Disease-modifying treatments in Alzheimer’s disease
Adenosine receptor signalling in Alzheimer’s disease
Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
Alzheimer’s disease: targeting the peripheral circulation
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer’s disease models
In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease
Publisher Correction to: Adenosine receptor signalling in Alzheimer’s disease
Targeting psychologic stress signaling pathways in Alzheimer’s disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
Adenosine receptor signalling in Alzheimer’s disease
Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
Alzheimer’s disease: targeting the peripheral circulation
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer’s disease models
In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease
Publisher Correction to: Adenosine receptor signalling in Alzheimer’s disease
Targeting psychologic stress signaling pathways in Alzheimer’s disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
Adenosine receptor signalling in Alzheimer’s disease
Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
Alzheimer’s disease: targeting the peripheral circulation
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer’s disease models
In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease
Publisher Correction to: Adenosine receptor signalling in Alzheimer’s disease
Targeting psychologic stress signaling pathways in Alzheimer’s disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis